Linezolid for the treatment of a heteroresistant Staphylococcus aureus shunt infection

Pediatric Neurosurgery

Volumn 41, Issue 2, 2005, Pages 102-104

  Cook, Aaron M ^a   Ramsey, Christian N ^a   Martin, Craig A ^a   Pittman, Thomas ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Gram positive organisms; Heteroresistance; Linezolid; Vancomycin; Ventriculitis

Indexed keywords

CEFTRIAXONE; LINEZOLID; NAFCILLIN; RIFAMPICIN; VANCOMYCIN;

ARTICLE; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; CLINICAL FEATURE; DRUG UTILIZATION; HUMAN; HYDROCEPHALUS; LABORATORY DIAGNOSIS; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SHUNT INFECTION; STAPHYLOCOCCUS AUREUS; TREATMENT INDICATION;

ACETAMIDES; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; HUMANS; INFANT, NEWBORN; MALE; OXAZOLIDINONES; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VENTRICULOPERITONEAL SHUNT;

EID: 22144435583     PISSN: 10162291     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085165     Document Type: Article

References (15)

1. Charles PG, Ward PB, Johnson PD, Howden BP, Grayson ML: Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin Infect Dis 2004;38:448-451.
2. Tenover FC, Biddle JW, Lancaster MV: Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg Infect Dis 2001;7:327-332.
3. Saiman L, Goldfarb J, Kaplan SL, Wible K, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB: Safety and tolerability of linezolid in children. Pediatr Infect Dis J 2003;22:S193-S200.
4. Steinmetz MP, Vogelbaum MA, De Georgia MA, Andrefsky JC, Isada C: Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid: Case report and review of the literature. Crit Care Med 2001;29:2383-2385.
5. Zeana C, Kubin CJ, Della-Latta P, Hammer SM: Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: Case report and review of the literature. Clin Infect Dis 2001;33:477-482.
6. Viale P, Pagani L, Cristini F, Stefini R, Bergomi R, Colombini P, Carosi G: Linezolid for the treatment of central nervous system infections in neurosurgical patients. Scand J Infect Dis 2002;34:456-459.
7. Gill CJ, Murphy MA, Hamer DH: Treatment of Staphylococcus epidermidis ventriculo-peritoneal shunt infection with linezolid. J Infect 2002;45:129-132.
8. Pfaulser B, Spiss H, Beer R, Kampfl A, Engelhardt K, Schober M, Schmutzhard E: Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: A prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg 2003;98:1040-1044.
9. Luer MS, Hatton J: Vancomycin administration into the cerebrospinal fluid: A review. Ann Pharmacother 1993;27:912-921.
10. Villani P, Regazzi MB, Marubbi F, Viale P, Pagani L, Cristini F, Cadeo B, Carosi G, Bergomi R: Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections. Antimicrob Agents Chemother 2002;46:936-937.
11. Mutnick AH, Biedenbach DJ, Turnidge JD, Jones RN: Spectrum and potency evaluation of a new oxazolidinone, linezolid: Report from the SENTRY antimicrobial surveillance program, 1998-2000. Diagn Microbiol Infect Dis 2002;43:65-73.
12. Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH: Linezolid vs vancomycin: Analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 2003;124:1789-1797.
13. Cha R, Brown WJ. Rybak MJ: Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus. In vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother 2003;47:3960-3963.
14. Bozdogan B, Esel D, Whitener C, Browne FA, Appelbaum PC: Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical Center. J Antimicrob Chemother 2003;52:864-868.
15. Gander S, Hayward K, Finch R: An investigation of the antimicrobial effects of linezolid on bacterial biofilms utilizing an in vitro pharmacokinetic model. J Antimicrob Chemother 2002;49:301-308.